FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases.

Castera L; Foucher J; Bertet J; Couzigou P; de Ledinghen V

doi:10.1002/hep.21019

FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases.

Castera L, Foucher J, Bertet J, Couzigou P, de Ledinghen V

MeSH — NLM indexing Biopsy Hepatitis C, Chronic / blood Hepatitis C, Chronic / diagnostic imaging Hepatitis C, Chronic / pathology Humans Liver Cirrhosis / blood Liver Cirrhosis / diagnostic imaging Liver Cirrhosis / pathology Sensitivity and Specificity Ultrasonography

Actions du personnel

Télécharger le PDF

Les fichiers sont réservés à un usage autorisé dans les canaux partenaires BioPredictive.

Fibrotest Actitest Letter Independent Group France

Auteurs (5)

Citation

Castera L, Foucher J, Bertet J, Couzigou P, de Ledinghen V. FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases. Hepatology. 2006;43(2):373-4; author reply 375-6. doi:10.1002/hep.21019.

Identifiants

DOI: 10.1002/hep.21019
PMID: 16440359

Tests

Maladies du foie

Atteintes hépatiques

Comparaisons

Région

Panier

Votre panier est vide.

Parcourez les publications et utilisez Ajouter au panier sur n'importe quelle page de détail pour constituer une archive ZIP à envoyer aux clients.

Parcourir les publications

FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases.

Autres publications de Castera L

Noninvasive Assessment of Liver Fibrosis.

Noninvasive Assessment of Liver Fibrosis.

Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.

Hepatitis B: are non-invasive markers of liver fibrosis reliable?

Noninvasive evaluation of NAFLD.

Non-invasive assessment of liver fibrosis: are we ready?

Sur le même sujet

An Invisible Early Steatosis Phenotype Defined for a Large Population-Based Cohort.

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Noninvasive Assessment of Liver Fibrosis.

Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter Study.

Toward non-invasive assessment strategies in autoimmune hepatitis.